Nadunolimab Clinical Trials
3 recruitingDrug
Phase 23Phase 12
Showing 1–3 of 3 trials
Recruiting
Phase 2
Immunoprevention for High-risk Lung Lesions
High-risk Lung Nodules
Robert Samstein59 enrolled1 locationNCT07284485
Recruiting
Phase 1Phase 2
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
M.D. Anderson Cancer Center40 enrolled1 locationNCT06548230
Recruiting
Phase 1Phase 2
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
Metastatic Microsatellite Stable Colorectal Carcinoma
Dan Feng24 enrolled1 locationNCT07281716